Skip to content
  • My Profile
  • Register
  • Log In
  • Watchlist
AlphaStreet

Market Intelligence Ecosystem

  • News
          • Technology
          • Consumer
          • Health Care
          • Industrials
          • Retail
          • Finance
          • Energy
          • IPO
          • Leisure & Entertainment
          • Research Summary
          • Other Industries
  • News
    • Consumer
    • Energy
    • Finance
    • Health Care
    • Industrials
    • IPO
    • Leisure & Entertainment
    • Other Industries
    • Research Summary
    • Retail
    • Technology
  • AlphaGraphs
  • AlphaStreet Intelligence
  • Log In
  • Register
  • My Profile
  • Watchlist

Categories

  • CEO Insights
  • Fund Manager Insights
  • Concall Highlights
  • Analysis
  • Concall Transcripts
  • AlphaGraphs

Pharmaceutical

Alkem Laboratories Ltd Q4FY25; 6% rise in Profits

June 5, 2025

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical

Ajanta Pharma Ltd Q4FY25; 11% rise in Profits

June 5, 2025

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).

Jubilant Ingrevia Ltd Q4FY25; 155% rise in Profits

June 4, 2025

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our

Abbott India Ltd Q4FY25; 87% rise in Profits

June 2, 2025

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within

Torrent Pharmaceuticals Ltd Q4FY25; 11% rise in Profits

May 21, 2025

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.

Alembic Pharmaceuticals Ltd Q4FY25; 12% fall in Profits

May 19, 2025

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company

Dr. Reddy’s Laboratories Ltd Q4FY25; 22% rise in Profits

May 9, 2025

Company Overview: Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active

Glaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in Profits

April 4, 2025

GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results:

ERIS Lifesciences Ltd Q3FY25; 14% fall in Profits

March 31, 2025

ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues

Dr Lal Pathlabs Ltd Q3FY25; 20% rise in Profits

March 26, 2025

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where

Sanofi India Ltd Q3FY25; 34% fall in Profits

March 19, 2025

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for

Cipla Ltd Q3FY25; 47% rise in Profits

March 19, 2025

Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q3FY25

Pfizer Ltd Q3FY25; 2% fall in Profits

March 7, 2025

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also

Aurobindo Pharma Ltd Q3FY25; 10% fall in Profits

February 28, 2025

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report

Astrazeneca Pharma India Ltd Q3FY25; 69% fall in Profits

February 27, 2025

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India

Ipca Laboratories Ltd Q3FY25; 25% rise in Profits

February 25, 2025

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25 of ₹2,245.00

Alkem Laboratories Ltd Q3FY25; 6% rise in Profits

February 24, 2025

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical

Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits

February 21, 2025

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company

Ajanta Pharma Ltd Q3FY25; 11% rise in Profits

February 21, 2025

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).

Abbott India Ltd Q3FY25; 88% fall in Profits

February 19, 2025

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within

ZYDUSLIFE Q3 2024-2025 Call Highlights: Profit Jump, Robust Margins & Expansion Plans!

February 17, 2025February 17, 2025

Zydus Lifesciences Ltd., a leading Indian Pharmaceutical company, in its Q3 earnings call discussed strong performance across multiple segments, with US business

Posts navigation

Older posts

© 2020 AlphaStreet Inc. All Rights Reserved

Quick Links

  • AlphaGraphs
  • Earnings Transcripts
  • Earnings Calls
  • Contact
  • Company
  • The Team

Contact Info

info@alphastreet.com

44053 Fremont Blvd,
Fremont, CA 94538

Top